Insights into the multi-step process of cancer have led to the development of targeted therapies that specifically address the genetic and molecular abnormalities driving cancer growth. For example, drugs that inhibit tyrosine kinases or restore the function of tumor suppressor genes are used in precision medicine. Understanding the stages and mechanisms of cancer progression also aids in the development of combination therapies that target multiple pathways simultaneously.
